As GLP-1 generic drugs flood the market, government steps up surveillance

New Delhi: With prices of GLP-1 drugs falling and their generic versions flooding the market, the government has cracked down on their misuse, inspecting 49 businesses and issuing notices, while also flagging the risks of unsafe consumption in a detailed advisory.To ensure ethical pharmaceutical practices, the Drug Controller General of India has intensified monitoring of unauthorized sale and promotion of medicines. In India, GLP-1 drugs can be prescribed only by endocrinologists, internal medicine specialists and cardiologists.Officials have raised concerns over their increasing on-demand availability through retail pharmacies, online platforms, wholesalers and wellness clinics. Inspections across the country found violations such as improper prescribing and misleading marketing. An advisory has directed manufacturers to stop advertisements promoting use without prescription, warning of license cancellation, fines and legal action.GLP-1 drugs used to treat type 2 diabetes and obesity carry risks if abused. Side effects range from vomiting to pancreatitis, kidney injury and bowel obstruction.